<p>This is part two of my MindMed Deep Dive. &nbsp;The primary focus of this video is an analysis of MindMed's acquisition of HealthMode. &nbsp;&nbsp;I also clear up a few things from the last video. &nbsp;&nbsp;Did the HealthMode acquisition make sense for MMED? What are their true AI / ML capabilities? Did I sell any shares after the last video? Clarification on my opinion on Departures Capital. &nbsp;Watch the video here: &nbsp;https://youtu.be/LUnEIRZmegE&nbsp;</p>
<p>Part 1 is here (<a href="https://www.youtube.com/watch?v=cfqdvm_Bz-w&amp;t=0s">https://youtu.be/cfqdvm_Bz-w</a>​).</p>

5:  Numinus Wellness Deep Dive.  Sleeping Giant or Spread Too Thin?

The Integration Conversation covers the emerging psychedelic industry. Watch as Hedge Fund veteran and psychedelic enthusiast Brom interviews psychedelic CEOs, performs in-depth analysis of psychedelic companies, and discusses the implications of psychedelics on our society. 

Prior to starting the Integration Conversation, Brom spent 7 years as a quant at multiple hedge funds.  Brom is a CFA charterholder and holds an MS in CS with a focus on Machine Learning from Georgia Tech.  In addition to running the Integration Conversation, Brom is focused on angel investing in psychedelic startups.